<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[TRANSCRIPT - Q&amp;A ZEALAND PHARMA]]></title><description><![CDATA[<p dir="auto">Transcript: Q&amp;A med Zealand Pharmas CEO Adam Steensberg fredag d. 17. november 2023.</p>
<p dir="auto">Moderator: Helge Larsen</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/116814_QA_Zealand_Pharma_2023_11_17.pdf" rel="nofollow ugc">116814_QA_Zealand_Pharma_2023_11_17.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/445839/transcript-qa-zealand-pharma</link><generator>RSS for Node</generator><lastBuildDate>Mon, 22 Jun 2026 01:11:53 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/445839.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 18 Nov 2023 14:40:51 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to TRANSCRIPT - Q&amp;A ZEALAND PHARMA on Sun, 19 Nov 2023 04:55:03 GMT]]></title><description><![CDATA[<p dir="auto">Opdateret analyse fra AktieInfo:</p>
<p dir="auto"><a href="https://www.aktieinfo.net/filer/zealandpharmaq32023.pdf" rel="nofollow ugc">https://www.aktieinfo.net/filer/zealandpharmaq32023.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9485609</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9485609</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Sun, 19 Nov 2023 04:55:03 GMT</pubDate></item></channel></rss>